Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients
暂无分享,去创建一个
I. Jaussent | K. Klouche | J. Cristol | A. Dupuy | B. Canaud | H. Leray-Moragués | M. Morena | A. Bargnoux | S. Badiou | Laure Patrier
[1] Josef Coresh,et al. Chronic kidney disease , 2012, The Lancet.
[2] A. Goux,et al. NADPH oxidase activity is associated with cardiac osteopontin and pro-collagen type I expression in uremia , 2011, Free radical research.
[3] Z. Massy,et al. PROGRESS IN UREMIC TOXIN RESEARCH: The Role of Oxidative Stress in Chronic Kidney Disease , 2009, Seminars in dialysis.
[4] M. Picot,et al. Homocysteine and inflammation as main determinants of oxidative stress in the elderly. , 2009, Free radical biology & medicine.
[5] S. Reese,et al. Nox‐2 Is a Modulator of Fibrogenesis in Kidney Allografts , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] A. Jurek,et al. The ability of HDL to inhibit VCAM-1 expression and oxidized LDL uptake is impaired in renal patients. , 2008, Clinical biochemistry.
[7] J. Cristol,et al. Regional Variations of Low-Density Lipoprotein Oxidizability in Hemodialysis Patients May Explain Discrepancies in Interventional Therapy on Oxidative Profile , 2008, Blood Purification.
[8] D. Grekas,et al. Increase in Oxidative Stress but Not in Antioxidant Capacity with Advancing Stages of Chronic Kidney Disease , 2007, American Journal of Nephrology.
[9] R. Natarajan,et al. Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes , 2007, Diabetes.
[10] Tom Greene,et al. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.
[11] L. Carbone,et al. Oxidative stress in aldosteronism. , 2006, Cardiovascular research.
[12] C Zoccali,et al. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. , 2006, Kidney international.
[13] N. Vaziri. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. , 2006, American journal of physiology. Renal physiology.
[14] Helmut Acker,et al. The oxygen sensing signal cascade under the influence of reactive oxygen species , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.
[15] K. Rosenblatt,et al. Regulation of Oxidative Stress by the Anti-aging Hormone Klotho*♦ , 2005, Journal of Biological Chemistry.
[16] Y. Sasaguri,et al. Local Expression of Platelet-Activating Factor-Acetylhydrolase Reduces Accumulation of Oxidized Lipoproteins and Inhibits Inflammation, Shear Stress-Induced Thrombosis, and Neointima Formation in Balloon-Injured Carotid Arteries in Nonhyperlipidemic Rabbits , 2005, Circulation.
[17] T. Hosoya,et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. , 2004, Kidney international.
[18] K. Prasad. C-Reactive Protein Increases Oxygen Radical Generation by Neutrophils , 2004, Journal of cardiovascular pharmacology and therapeutics.
[19] J. Morrow,et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. , 2004, Kidney international.
[20] M. Landray,et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] D. Stengel,et al. Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases Atherosclerosis , 2003, Circulation.
[22] Gabor Kaley,et al. Increased Superoxide Production in Coronary Arteries in Hyperhomocysteinemia: Role of Tumor Necrosis Factor-&agr;, NAD(P)H Oxidase, and Inducible Nitric Oxide Synthase , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[23] M. Goolsby. National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, Journal of the American Academy of Nurse Practitioners.
[24] J. Gamble,et al. Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins. , 2001, Atherosclerosis.
[25] D. Shih,et al. The role of high-density lipoproteins in oxidation and inflammation. , 2001, Trends in cardiovascular medicine.
[26] S. Friedman,et al. Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. , 2001, American journal of physiology. Endocrinology and metabolism.
[27] J. Himmelfarb,et al. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. , 2000, Kidney international.
[28] S. Reddy,et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. , 2000, Journal of lipid research.
[29] G. Lonnemann. Chronic Inflammation in Hemodialysis: The Role of Contaminated Dialysate , 2000, Blood Purification.
[30] D. Tarng,et al. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. , 2000, Kidney international.
[31] T. Dantoine,et al. Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] S. Liou,et al. Increase in Resting Levels of Superoxide Anion in the Whole Blood of Uremic Patients on Chronic Hemodialysis , 1998, Blood Purification.
[33] P. Jungers,et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.
[34] I. Young,et al. Oxidative stress in chronic renal failure. , 1998, Free radical research.
[35] H. Lander. An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] P. Jungers,et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. , 1996, Kidney international.
[37] D. Stafforini,et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. , 1995, The Journal of clinical investigation.
[38] K. Mcleish,et al. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. , 1995, Journal of the American Society of Nephrology : JASN.
[39] P. McNamee,et al. Oxidative stress in haemodialysis. , 1994, QJM : monthly journal of the Association of Physicians.
[40] R. Gans,et al. C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. , 2004, Atherosclerosis.
[41] B. Descomps,et al. Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the olympus analyzer , 2003, Journal of clinical laboratory analysis.
[42] L Guize,et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. , 1997, Hypertension.
[43] J. Castel,et al. [Oxidative stress and chronic renal insufficiency: what can be a prophylactic approach?]. , 1997, Comptes rendus des seances de la Societe de biologie et de ses filiales.
[44] S Greenland,et al. The impact of confounder selection criteria on effect estimation. , 1989, American journal of epidemiology.